76 results
Page 2 of 4
424B4
b8ny4heu6a5 5fx5
13 Sep 21
Prospectus supplement with pricing info
4:16pm
DRS
hrl0y
26 Aug 21
Draft registration statement
12:00am
8-K
EX-2.1
ztzhcxypov
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
DEF 14A
djzpveaimk5d
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
oqr5a4mfkf5hg2n7h
9 Apr 21
Preliminary proxy
4:16pm
424B4
pdrmx sye
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
lc2784lomnuur8hunif
25 Mar 21
Draft registration statement
12:00am
10-K
g6xvla6cwk 2t
22 Mar 21
Annual report
4:22pm
8-K
EX-1.1
i4npqo
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.8
zf8q 9zht3odx14
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.1
f1ig b5cjl3z
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.10
xgs6v7fpeod8 xf
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-4.1
n83vzy
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.9
hqk 8lpt8qj57sn
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.3
0lkd5
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-8
EX-10.1
undy6pg5uc6 6hwzr5
23 Nov 20
Registration of securities for employees
5:06pm